Pharmaceutical Sector in Egypt
Sectoral review: Pharmaceutical Sector
1 . Advantages 2 . Classification 3. Regulatory framework
3. 1 . Regulating body a few. 2 . Charges
3. a few. TRIPS
3 4 four
4. Marketplace analysis
4. 1 . Market structure some. 2 . Usage 4. a few. Production 4. 4. Key players
5. 1 . Exports a few. 2 . Imports 5. three or more. Balance of trade
6. SWOT analysis several. Outlook eight. Recommendations on the lookout for. Conclusion Appendix References
10 12 13 13
a couple of
Sectoral review: Pharmaceutical Industry
Producing treatments is a strategic industry due to its importance on the social level and significant role in protecting the human health. Immeasureable dollars are annually used research and development all over the world to support this industry planning to increase human's ability to encounter different kinds of conditions which is obviously reflected inside the rising life span for people particularly in industrial countries where medication production is extremely concentrated in those countries. This sector has started in Egypt with Tal'at Harb and the institution of the first Egyptian pharmaceutical company in 1939 as of " Misr Business for Pharmaceuticals" believing inside the strategic significance of a strong national pharmaceutical sector. It has undergone many alterations along the record witnessing a large variation in the key players controlling the industry, attracting a large number of investments to that particular growing field that varieties about 30% of the drugs supply in the MENA marketplace, according to the American Chamber of Commerce in Egypt. So , this paper is spotting the main highlights of the pharmaceutical drug sector which includes demand, source, patterns of trade and regulatory framework that organizes the sector. The paper also takes up strengths in the sector and particularly after liberalizing the industry, bringing out an efficient subscription system for new medicines and other factors that have collectively helped to make a start in the performance of this sector. However , additionally, it mentions depressed views consider some hazards endangering that sector like the new prices system the Ministry of Health really wants to adopt as well as the TRIPS agreement that may in a negative way affect the pharmaceutical industry in Egypt.
Sectoral survey: Pharmaceutical Industry
The pharmaceutical drug industry develops, produces and markets medications licensed for use as medication. There are different categories of treatments like: 2. OTC drugs and prescription medications Over The Counter (OTC) pharmaceuticals can be taken with no need to a pharmaceutical drug in contrast to prescribed drugs. * Branded and general medicine Patented medicine may be the original the one which is first of all produced and generic medication is the duplicate of the initial medicine. Patents form the major percentage of the value of drug demand. On the other hand, general medicine symbolized 60. 2% of the benefit of the pharmaceutical drug sector in 2008. 2. Biologics & biosimilars Neurological medicines will be produced applying biological techniques and biosimilar medicines happen to be copies of original natural medicines.
3- Regulatory structure
3/1) Regulating body The Egyptian Medication Authority (EDA), follows the Ministry of Health, may be the regulatory physique responsible for supervising the pharmaceutic sector. In addition, there are 3 sub-organizations comes after EDA: * The Central Administration of Pharmaceutical Affairs (CAPA) that is responsible for administrative regulations. 2. National Corporation for Drug Control & Research (NODCAR) to watch over drugs. * National Firm for Study & Control of Biologics (NORCB) to control biologics meeting the WHO requirements and worldwide standards.
Sectoral review: Pharmaceutical Market
3/2) Costs Before September 2009, the Pricing Panel in the Ministry of Wellness was deciding the profit perimeter ceiling several types of drugs through the " cost plus system". The profit...
References: " Industry Prediction Senario. " www.businessmonitor.com. Business Monitor International, 14 Nov. 2009. Internet. 15 Sep 2010.. " WPM Q2 2010. " www.marketresearch.com. Espicom Healthcare Cleverness, Q2 2010. Web. 15 Sep 2010.. " Neurological and Biosimilar Medicines. " www.europabio.org. Europabio, n. g. Web. 15 Sep 2010.. " P h my spouse and i l u s um p h y: To R We P S i9000 a capital t t elizabeth m s t t t o s big t r i k como tambem a b a l a n c e. " w watts w. t t o. o 3rd there’s r g. T o ur l d T ur a d e Firm, n. m. Web. 12-15 Sep 2010.. " Elizabeth g yp t -- I and c 3rd there’s r e a s i d g i n v e t t m e in t i n p h a r meters a c e u t we c a l s e c t um r. " www.english.globalarabnetwork. Global Arab Network, 15 Feb. 2010. Internet. 15 Sep 2010.. " Progress in Essential Medications and Drugs Policy 98 -1999. " www.apps.who.int. Globe Health Business, n. g. Web. 18 Sep 2010.. " Operate Performance HS. " www.intracen.org. International Control Center, 2008. Web. 21 years old Sep 2010.. " T h electronic E g yp to i a n L h a r meters a c e u t my spouse and i c a l I n m u h t ur y. " w w w. u b we c talking to. com. UBIC Consulting, d. d. Web. 31 Oct 2010.. " R elizabeth c electronic n big t l con r electronic l como tambem a s at the d m a ur k elizabeth t s i9000 t u d con: E g yp capital t P l a 3rd there’s r m a c electronic u to i c a m s & H e a l to h c a 3rd there’s r e R e p o 3rd there’s r t Q 3 2010. " www.pr-inside.com. PR-inside, and. d. Internet. 31 April 2010..
Sectoral survey: Pharmaceutical Sector
" The center East: Pharma's New Frontier. " www.contractpharma.com. PRinside, d. d. Internet. 31 March 2010.. " E g yp to p l a r m a a d d w i u t e c they would: S u b -- s at the c big t o l u l d a t at the. " t w w. e we u. c o m. E c o n o m i s i9000 t Cleverness Unit, Jan 21 2010. Web. 31 Oct 2010. " I n versus e s t my spouse and i n At the g yp t. " w t w. m o c s big t o c. c um m. Meters i in i s t 3rd there’s r y o f I n sixth is v e s i9000 t meters e and t, two 0 0 8. T e n. 3 you O c t 2010..
www.holdipharma.com.eg www.eipico.com.eg www.amoun.com www.intracen.org www.espicom.com
The information contained in this newsletter is based on options that AlexBank believes to become reliable and accurate. But the bank does not make any guarantee for the accuracy or perhaps reliability of such information. All viewpoints and estimates included in this survey are susceptible to change with out prior notice. Nothing here constitutes a package, solicitation to the purchase or sale of any kind of products, services or doing any investments. AlexBank will not be liable for any loss or damages incurred or suffered as a result of using its journals and in using the Website is actually contents and functions. The info and/or info in the publications are not regarded official document in any arguments or clashes reviewed by simply security or regulatory authorities. The Bank retains all the fictional and moral rights about its data and research and no a part of this publication or excerpt of the content could possibly be redistributed, reproduced or conveyed in any type, written or perhaps oral, to the third party without a prior crafted consent of AlexBank and also referring to the source.
Industry Segmentation in Telecom sector: Its Part and Scope in Cell Services in India Fuzy Market segmentation plays a really crucial position in service sector. It helps in…...
White ideas of enslavement by The united kingdom: In the wake of the Stamps Act turmoil, some People in the usa began to speak and talk about a story by…...
п»ї Learning styles and effective study habits My personal top scores from the applying multiple intelligence to enhance studying and learning tutorial was musical/rhythm, intrapersonal, and sociable.…...